These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7596496)

  • 1. Pituitary surgery in elderly patients with acromegaly.
    Puchner MJ; Knappe UJ; Lüdecke DK
    Neurosurgery; 1995 Apr; 36(4):677-83; discussion 683-4. PubMed ID: 7596496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
    Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P; Laws ER; Elliott E
    Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly.
    Biermasz NR; van Dulken H; Roelfsema F
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4596-602. PubMed ID: 11134114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly.
    Abe T; Lüdecke DK
    Clin Endocrinol (Oxf); 1999 Jan; 50(1):27-35. PubMed ID: 10341853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience.
    Ahmed S; Elsheikh M; Stratton IM; Page RC; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 1999 May; 50(5):561-7. PubMed ID: 10468920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for cure in acromegaly: report of a case apparently cured in which persisting tumor was found at autopsy.
    Wrightson P; Holdaway IM; Synek BJ
    Neurosurgery; 1984 Jun; 14(6):750-5. PubMed ID: 6379495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.
    Attanasio R; Epaminonda P; Motti E; Giugni E; Ventrella L; Cozzi R; Farabola M; Loli P; Beck-Peccoz P; Arosio M
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3105-12. PubMed ID: 12843150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients.
    Valdemarsson S; Bramnert M; Cronquist S; Elner A; Eneroth CM; Hedner P; Lindvall-Axelsson M; Nordström CH; Strömblad LG
    J Intern Med; 1991 Jul; 230(1):49-54. PubMed ID: 1906090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
    Freda PU; Wardlaw SL; Post KD
    J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients.
    Minniti G; Jaffrain-Rea ML; Esposito V; Santoro A; Moroni C; Lenzi J; Tamburrano G; Cassone R; Cantore G
    Acta Neurochir (Wien); 2001 Dec; 143(12):1205-11. PubMed ID: 11810383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value and results of trans-sphenoid surgery of the hypophysis in acromegaly].
    Knappe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(20):1013-7. PubMed ID: 1441638
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry].
    Jaquet P; Cortet-Rudelli Ch; Sassolas G; Morange-Ramos I; Chanson P; Brue T; Andrieu JM; Beckers A; Bertherat J; Borson-Chazot F; Brassier G; Caron P; Cogne M; Cottier JP; Delemer B; Dufour H; Enjalbert A; Figarella-Branger D; Gaillard R; Gueydan M; Jan M; Kuhn JM; Raingeard I; Regis J; Roger P; Rohmer V; Sadoul JL; Saveanu A; Tabarin A; Travers N; Trouillas J;
    Ann Endocrinol (Paris); 2003 Dec; 64(6):434-41. PubMed ID: 15067248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.